The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
Open accessAbstract
BACKGROUND: Embolic strokes of undetermined source represent 20% of ischemic strokes and are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an oral factor Xa inhibitor, may result in a lower risk of recurrent stroke than aspirin. METHODS: We compared the efficacy and safety of rivaroxaban (at a daily dose of 15 mg) with aspirin (at a daily dose of 100 mg) for the prevention of recurrent stroke in patients with recent ischemic stroke that was presumed to be from cerebral embolism but without arterial stenosis, lacune, or an identified cardioembolic source. The primary efficacy outcome was the first recurrence of ischemic or hemorrhagic stroke or systemic embolism in a time-to-event analysis; the primary safety outcome was the rate of major bleeding. RESULTS: A total of 7213 participants were enrolled at 459 sites; 3609 patients were randomly assigned to receive rivaroxaban and 3604 to receive aspirin. Patients had been followed for a median of 11 months when the trial was terminated early because of a lack of benefit with regard to stroke risk and because of bleeding associated with rivaroxaban. The primary efficacy outcome occurred in 172 patients in the rivaroxaban group (annualized rate, 5.1%) and in 160 in the aspirin group (annualized rate, 4.8%) (hazard ratio, 1.07; 95% confidence interval [CI], 0.87 to 1.33; P=0.52). Recurrent ischemic stroke occurred in 158 patients in the rivaroxaban group (annualized rate, 4.7%) and in 156 in the aspirin group (annualized rate, 4.7%). Major bleeding occurred in 62 patients in the rivaroxaban group (annualized rate, 1.8%) and in 23 in the aspirin group (annualized rate, 0.7%) (hazard ratio, 2.72; 95% CI, 1.68 to 4.39; P<0.001). CONCLUSIONS: Rivaroxaban was not superior to aspirin with regard to the prevention of recurrent stroke after an initial embolic stroke of undetermined source and was associated with a higher risk of bleeding. (Funded by Bayer and Janssen Research and Development; NAVIGATE ESUS ClinicalTrials.gov number, NCT02313909 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
SCHULMAN, S., & KEARON, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,009
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Embolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Self-citationClopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
Johnston, S. C., Easton, J. D., Farrant, M., Barsan, W., Conwit, R. A., Elm, J. J., Kim, A. S., Lindblad, A. S., & Palesch, Y. Y. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800410 · Cited by 1,352
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Mas, J.-L., Derumeaux, G., Guillon, B., Massardier, E., Hosseini, H., Mechtouff, L., Arquizan, C., Béjot, Y., Vuillier, F., Detante, O., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705915 · Cited by 1,183
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Søndergaard, L., Kasner, S. E., Rhodes, J. F., Andersen, G., Iversen, H. K., Nielsen-Kudsk, J. E., Settergren, M., Sjöstrand, C., Roine, R. O., Hildick-Smith, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707404 · Cited by 1,137
Self-citationLong-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
Saver, J. L., Carroll, J. D., Thaler, D. E., Smalling, R. W., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610057 · Cited by 1,127
Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation: – The J-ROCKET AF Study –
Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S.-I., Uchiyama, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0454 · Cited by 641
Self-citationFox, K. A. A., Piccini, J. P., Wojdyla, D., Becker, R. C., Halperin, J. L., Nessel, C. C., Paolini, J. F., Hankey, G. J., Mahaffey, K. W., Patel, M. R., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr342 · Cited by 608
Self-citation2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
Hicks, K. A., Tcheng, J. E., Bozkurt, B., Chaitman, B. R., Cutlip, D. E., Farb, A., Fonarow, G. C., Jacobs, J. P., Jaff, M. R., Lichtman, J. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.12.018 · Cited by 603
López-López, J. A., Sterne, J. A. C., Thom, H. H. Z., Higgins, J. P. T., Hingorani, A. D., Okoli, G. N., Davies, P. A., Bodalia, P. N., Bryden, P. A., Welton, N. J., et al. (2017) · BMJ · doi:10.1136/bmj.j5058 · Cited by 547
Li, L., Yiin, G. S., Geraghty, O. C., Schulz, U. G., Kuker, W., Mehta, Z., & Rothwell, P. M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00132-5 · Cited by 433
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart, R. G., Tonarelli, S. B., & Pearce, L. A. (2005) · Stroke · doi:10.1161/01.str.0000170642.39876.f2 · Cited by 355
Self-citationHankey, G. J., Patel, M. R., Stevens, S. R., Becker, R. C., Breithardt, G., Carolei, A., Diener, H.-C., Donnan, G. A., Halperin, J. L., Mahaffey, K. W., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70042-x · Cited by 354
Self-citationSaver, J. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503946 · Cited by 276
The effect of food on the absorption and pharmacokinetics of rivaroxaban
Stampfuss, J., Kubitza, D., Becka, M., & Mueck, W. (2013) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201812 · Cited by 216
Aortic Arch Plaques and Risk of Recurrent Stroke and Death
Di Tullio, M. R., Russo, C., Jin, Z., Sacco, R. L., Mohr, J. P., & Homma, S. (2009) · Circulation · doi:10.1161/circulationaha.108.811935 · Cited by 206
Diener, H.-C., Easton, J. D., Granger, C. B., Cronin, L., Duffy, C., Cotton, D., Brueckmann, M., & Sacco, R. L. (2015) · International Journal of Stroke · doi:10.1111/ijs.12630 · Cited by 166
Geisler, T., Poli, S., Meisner, C., Schreieck, J., Zuern, C. S., Nägele, T., Brachmann, J., Jung, W., Gahn, G., Schmid, E., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493016681019 · Cited by 163
Complex Plaques in the Proximal Descending Aorta
Harloff, A., Simon, J., Brendecke, S. M., Assefa, D., Helbing, T., Frydrychowicz, A. P., Weber, J., Olschewski, M., Strecker, C., Hennig, J., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.577775 · Cited by 146
Interpreting Geographic Variations in Results of Randomized, Controlled Trials
Yusuf, S., & Wittes, J. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510065 · Cited by 104
Hart, R. G., Sharma, M., Mundl, H., Shoamanesh, A., Kasner, S. E., Berkowitz, S. D., Paré, G., Kirsch, B., Pogue, J., Pater, C., et al. (2016) · European Stroke Journal · doi:10.1177/2396987316663049 · Cited by 97
Self-citationKasner, S. E., Lavados, P. M., Sharma, M., Wang, Y., Wang, Y., Dávalos, A., Shamalov, N. A., Cunha, L., Lindgren, A., Mikulík, R., et al. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.01.027 · Cited by 54
Self-citationMao, L., Li, C., Li, T., & Yuan, K. (2013) · Vascular · doi:10.1177/1708538113490423 · Cited by 32
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
Metadata
- Authors
- Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., Swaminathan, B., Lavados, P., Wang, Y., Wang, Y., Davalos, A., Shamalov, N., Mikulik, R., Cunha, L., Lindgren, A., Arauz, A., Lang, W., Czlonkowska, A., Eckstein, J., Gagliardi, R. J., Amarenco, P., Ameriso, S. F., Tatlisumak, T., Veltkamp, R., Hankey, G. J., Toni, D., Bereczki, D., Uchiyama, S., Ntaios, G., Yoon, B.-W., Brouns, R., Endres, M., Muir, K. W., Bornstein, N., Ozturk, S., O’Donnell, M. J., De Vries Basson, M. M., Pare, G., Pater, C., Kirsch, B., Sheridan, P., Peters, G., Weitz, J. I., Peacock, W. F., Shoamanesh, A., Benavente, O. R., Joyner, C., Themeles, E., & Connolly, S. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-06-07
- Volume
- 378
- Issue
- 23
- Pages
- 2191-2201
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2803966697
- Cited by
- 1,028
- References
- 29
- FWCI
- 83.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.